|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.890 EUR | +5.10% |
|
+17.74% | +93.92% |
| 06-09 | Genfit flat despite positive news and Kepler Cheuvreux backing |  |
| 06-09 | Genfit's NIS4-powered NASHnext test now available on Labcorp OnDemand | |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 548M | - | ||||
| 43.51B | |||||
| 33.29B | - | - | - | - | - |
| 29.9B | |||||
| 29.34B | |||||
| 25.42B |
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Charts GENFIT
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
